Magnitude Biosciences

We are a specialist Contract Research Organisation (CRO) who help industry and academia progress their research projects via our team of expert scientists, C. elegans services and unique automated imaging technology.

Our C. elegans studies are customised to answer your key research questions and generate high-quality, reproducible data to accelerate your research project to the next stage.

We were founded in 2018 by a team of the world’s leading C. elegans and automated imaging experts who shared the vision of bringing the benefits of this unique research approach to industry, helping to play our part in accelerating the development of new drug therapies and other research advances to improve human and environmental health.

We help biotechnology companies, pharmaceutical companies, health products companies, manufacturing (including agri-manufacturing and green manufacturing) and anyone else doing Research and Development (R&D) who can benefit from our C. elegans healthspan technology and expertise.

Our key research areas include early preclinical drug discovery projects, microbiome, ageing, neurodegeneration and neurodegenerative diseases, environmental toxicity, reproductive toxicity, and C. elegans transgenics.